BTMD - NASDAQ

biote Corp.

biote Corp.

BTMD·NASDAQ

$2.11

+5.5%
HealthcareMedical - Care Facilities

biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas.

StatementsValue Model

At a Glance

Live Snapshot
Market Cap$93.07M
EPS0.8600
P/E Ratio2.45
Earnings Date08/05/2026

btmd

Total Payables

Last Annual Value

6.83M

3-Year CAGR

10%

5-Year CAGR

23%

10-Year CAGR

8%

biote Corp.

biote Corp. Competitors Analysis of Total Payables

BTMD · NASDAQ
CompanyTotal Payables
CAGR 3Y
CAGR 5Y
CAGR 10Y
BTMD logo
biote Corp.
NASDAQ:BTMD
6.83M
17.8%9.4%N/A 
ANIK logo
Anika Therapeutics, Inc.
NASDAQ:ANIK
6.04M
-6.7%-4.6%10.1%
VOR logo
Vor Biopharma Inc.
NASDAQ:VOR
5.13M
84.6%27.1%N/A
LUCD logo
Lucid Diagnostics Inc.
NASDAQ:LUCD
970.00K
-54.8%-21.0%N/A
DCGO logo
DocGo Inc.
NASDAQ:DCGO
11.45M
-25.5%-6.3%N/A
MBOT logo
Microbot Medical Inc.
NASDAQ:MBOT
511.00K
12.7%12.9%-0.0%
RCEL logo
AVITA Medical, Inc.
NASDAQ:RCEL
8.96M
33.2%27.0%N/A
RPID logo
Rapid Micro Biosystems, Inc.
NASDAQ:RPID
4.14M
23.0%-2.6%N/A
LNSR logo
LENSAR, Inc.
NASDAQ:LNSR
18.98M
67.9%47.8%N/A
TIL logo
Instil Bio, Inc.
NASDAQ:TIL
779.00K
-13.7%-33.7%N/A
SPRO logo
Spero Therapeutics, Inc.
NASDAQ:SPRO
1.08M
-15.2%-0.5%-0.6%
biote Corp.

biote Corp. Fair Value Envelope

BTMD · NASDAQ

Our analysis suggests that BTMD has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $2.11, this represents a potential HIDDEN relative to our calculated worth for biote Corp..

HIDDEN
Intrinsic Value
Current Price: $2.11

Related Guides

Blog Categories

Continue your BTMD research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens
1

Snapshot

Start with context, operating signals, and key market metrics.

2

Value Model

Stress test fair value across bear, base, and bull assumptions.

3

Statements

Validate revenue quality, margins, and balance sheet durability.

4

Earnings Call

Read management commentary and compare it with reported outcomes.

5

Dividends

Check payout sustainability and long-term distribution behavior.

6

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.